Medicare Part D coverage · 1.6 · RxCUI 1649964
1.6 ML filgrastim 0.3 MG/ML Injection [Neupogen]
Per the CMS 2026 Part D formulary file, 1.6 ML filgrastim 0.3 MG/ML Injection [Neupogen] is covered by 268 Medicare Part D plans (5.3% of enrollable products), averaging Tier 4.5, with prior authorization required on 71.4% of covering formularies.
- 5.3%
- Plan coverage
- 268
- Plans covering
- T4.5
- Avg tier
- 71.4%
- Prior auth required
What the CMS Formulary Data Shows for 1.6 ML filgrastim 0.3 MG/ML Injection [Neupogen]
Per the CMS 2026 Part D formulary file, 1.6 ML filgrastim 0.3 MG/ML Injection [Neupogen] (RxNorm concept RXCUI 1649964, generic name 1.6) appears on 14 distinct formulary files spanning 268 Medicare Part D plan offerings - 5.3% of enrollable Part D products, selective placement; verify formulary inclusion before enrolling. Tier placement ranges from Tier 1 to Tier 5, with a cross-plan average of Tier 4.5.
Real-world access to 1.6 ML filgrastim 0.3 MG/ML Injection [Neupogen] depends on utilization management as much as tier placement: 71.4% of covering formularies require prior authorization. 7.1% require step therapy. 0% apply quantity limits.
Historical spending context from the CMS Medicare Part D Drug Spending Dashboard shows 1,092 Part D beneficiaries filled 1.6 ML filgrastim 0.3 MG/ML Injection [Neupogen] in 2023, with total plan-and-beneficiary spending of $9,654,765 and an average per-beneficiary annual cost of $8,841.36. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry 1.6 ML filgrastim 0.3 MG/ML Injection [Neupogen] today.
Coverage Details
- Formularies covering
- 14
- Plans covering
- 268
- Coverage rate
- 5.3%
- Tier range
- Tier 1 – Tier 5
- Average tier
- Tier 5, Specialty
Restrictions
- Prior authorization required
- 71.4% of formularies
- Step therapy required
- 7.1% of formularies
- Quantity limits
- 0% of formularies
2023 Medicare Spending
- Beneficiaries
- 1,092
- Total spending
- $9,654,765
- Avg per beneficiary
- $8,841.36
Tier Distribution Across Plans
Medicare Advantage Plans (MA-PD) Covering 1.6 ML filgrastim 0.3 MG/ML Injection [Neupogen]
100 Medicare Advantage plans with Part D drug coverage include this drug.
| Plan | Insurer | Tier | PA | Premium | States |
|---|---|---|---|---|---|
| Platino Blindao (HMO D-SNP) | Triple S Advantage, Inc. | T1 | Yes | $0 | PR |
| Platino Enlace (HMO D-SNP) | Triple S Advantage, Inc. | T1 | Yes | $0 | PR |
| Platino Advance (HMO D-snp) | Triple S Advantage, Inc. | T1 | Yes | $0 | PR |
| Platino Plus (HMO D-snp) | Triple S Advantage, Inc. | T1 | Yes | $0 | PR |
| CalOptima Health OneCare Complete (HMO D-SNP) | Orange County Health Authority | T2 | Yes | $0 | CA |
| Select Health Medicare Essential (HMO) | Selecthealth, Inc. | T5 | Yes | $0 | UT |
| Select Health Medicare Essential (HMO) | Selecthealth, Inc. | T5 | Yes | $0 | NV |
| Select Health Medicare Dual (HMO D-SNP) | Selecthealth, Inc. | T5 | Yes | $0 | UT |
| Select Health Medicare Essential (HMO) | Selecthealth, Inc. | T5 | Yes | $0 | UT |
| Select Health Medicare + Kroger (HMO) | Selecthealth, Inc. | T5 | Yes | $0 | NV |
| Select Health Medicare + Kroger (HMO) | Selecthealth, Inc. | T5 | Yes | $0 | UT |
| Select Health Medicare Essential (HMO) | Selecthealth, Inc. | T5 | Yes | $0 | CO |
| Select Health Medicare Essential (HMO) | Selecthealth, Inc. | T5 | Yes | $0 | CO |
| Select Health Medicare + Kroger (HMO) | Selecthealth, Inc. | T5 | Yes | $0 | CO |
| Select Health Medicare Flex (HMO) | Selecthealth, Inc. | T5 | Yes | $0 | CO |
| Select Health Medicare + Kroger (HMO) | Selecthealth, Inc. | T5 | Yes | $0 | CO |
| Select Health Medicare Active (HMO) | Selecthealth, Inc. | T5 | Yes | $0 | CO |
| Select Health Medicare Dual (HMO D-SNP) | Selecthealth, Inc. | T5 | Yes | $0 | NV |
| Select Health Medicare Wellness (HMO) | Selecthealth, Inc. | T5 | Yes | $0 | NV |
| Anthem Medicare Advantage (HMO-POS) | Blue Cross OF California | T5 | Yes | $0 | CA |
Show the next 30 plans
Showing top 50 of 100 plans.
Frequently Asked Questions
Is 1.6 ML filgrastim 0.3 MG/ML Injection [Neupogen] covered by Medicare Part D?
Yes, 1.6 ML filgrastim 0.3 MG/ML Injection [Neupogen] is covered by 268 Medicare Part D plans (5.3% of all Part D formularies).
What tier is 1.6 ML filgrastim 0.3 MG/ML Injection [Neupogen] on Medicare Part D plans?
1.6 ML filgrastim 0.3 MG/ML Injection [Neupogen] averages Tier 4.5 across Part D plans, ranging from Tier 1 to Tier 5.
Does 1.6 ML filgrastim 0.3 MG/ML Injection [Neupogen] require prior authorization?
71.4% of Part D formularies require prior authorization for 1.6 ML filgrastim 0.3 MG/ML Injection [Neupogen]. Step therapy: 7.1%. Quantity limits: 0%.
How much does Medicare spend on 1.6 ML filgrastim 0.3 MG/ML Injection [Neupogen]?
In 2023, total Medicare Part D spending on 1.6 ML filgrastim 0.3 MG/ML Injection [Neupogen] was $9,654,765, covering 1,092 beneficiaries. The average spend per beneficiary was $8,841.36.
Read our methodology - how this data is sourced, computed, and verified.
Nationwide similar Part D drugs
Data-derived peers across the CMS Part D formulary extract: nearest average tier placement and nearest prior-authorization rate. Not therapeutic alternatives or same-generic strengths.
Closest average formulary tier
- 0.6 ML pegfilgrastim-cbqv 10 MG/ML Auto-Injector [Udenyca] T4.5
- 1.7 ML denosumab-nxxp 70 MG/ML Injection [Bilprevda] T4.5
- 1 ML tbo-filgrastim 0.3 MG/ML Injection [Granix] T4.5
- 0.5 ML filgrastim 0.6 MG/ML Prefilled Syringe [Neupogen] T4.5
- 0.8 ML filgrastim 0.6 MG/ML Prefilled Syringe [Neupogen] T4.5
- 1 ML filgrastim 0.3 MG/ML Injection [Neupogen] T4.5
Similar prior-authorization rate
- testosterone enanthate 200 MG/ML Injectable Solution 71.3% PA
- letermovir 20 MG Oral Pellet [Prevymis] 71.2% PA
- 0.5 ML interferon beta-1a 0.044 MG/ML Auto-Injector [Rebif] 71.7% PA
- 0.5 ML interferon beta-1a 0.088 MG/ML Prefilled Syringe [Rebif] 71.7% PA
- 1 ML peginterferon alfa-2a 0.18 MG/ML Injection [Pegasys] 70.9% PA
- diclofenac sodium 20 MG/ML Topical Solution 72% PA